NCT02652416 Safety, Tolerability and Pharmacokinetics of BI 1026706 in Healthy Chinese and Japanese Male Volunteers Status COMPLETED Phase PHASE1
NCT02642614 Safety, Tolerability and Pharmacokinetics and Effect on Inflammation of Oral BI 1026706 in Patients With COPD Status COMPLETED Phase PHASE1
NCT02640612 Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT02637973 Effects of Empagliflozin on Liver Fat Content, Energy Metabolism and Body Composition in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT02636907 Assessment of the Handling Experience With the BI 695501 Autoinjector in Patients With Rheumatoid Arthritis Followed by an Extension Phase Using BI 695501 Prefilled Syringe Status COMPLETED Phase PHASE2
NCT02635750 Investigation of Pharmacokinetic Drug-drug Interaction of BI 409306 and Donepezil in Healthy Male and Female Subjects Status COMPLETED Phase PHASE1
NCT02632747 Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN Study Status COMPLETED Phase PHASE2
NCT02632721 A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML) Status COMPLETED Phase PHASE1/PHASE2
NCT02631057 Length of Stay in NVAF Patients Hospitalized and Initiated With Dabigatran or Warfarin in Japan Status COMPLETED Phase N/A
NCT02629965 Comparing the Efficacy of Tiotropium + Olodaterol Fixed Dose Combination (FDC) Over Tiotropium in Improvement of Lung Hyperinflation, Exercise Capacity and Physical Activity in Japanese COPD Patients Status COMPLETED Phase PHASE3
NCT02629354 To Determine Blood Concentrations of Ibuprofen and Caffeine in a Tablet Against Ibuprofen Alone From Another Tablet Status COMPLETED Phase PHASE1
NCT02624492 To Determine the Dose of BI 836826-GemOx and the Efficacy of BI 836826-GemOx Versus R-GemOx in Patients With Relapsed/Refractory DLBCL Status COMPLETED Phase PHASE2
NCT02622581 Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients Status RECRUITING Phase N/A
NCT02606903 Pharmacokinetics and Safety of BI 695501 Administered Via Prefilled Syringe or Autoinjector Status COMPLETED Phase PHASE1
NCT02606877 A Study to Compare the Amount of Nintedanib and Pirfenidone in the Blood When Nintedanib and Pirfenidone Are Given Separately or in Combination Status COMPLETED Phase PHASE4
NCT02597998 Metabolism and Pharmacokinetics of [14C]-BI 409306 After Administration as Oral Solution in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02597933 A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis Status COMPLETED Phase PHASE3